GLP-1 weight loss medication, prescribed if clinically appropriate. Prescribed online, delivered monthly.
Free shipping · cancel anytime, no contracts (see Terms) · dispensed medication is not refundable
Semaglutide is a GLP-1 receptor agonist — a class of medications originally developed for type 2 diabetes that has shown remarkable weight loss results. It works by mimicking a natural hormone that regulates appetite and blood sugar. Manufacturer trials of the branded FDA-approved product (Wegovy) reported average weight loss of 15–17% of body weight over 68 weeks. Compounded semaglutide is not FDA-approved and has not been studied in those trials, so those figures do not describe expected Heyday outcomes. Individual results vary.
Semaglutide activates GLP-1 receptors in the brain that control hunger and satiety. This reduces appetite, slows gastric emptying (so you feel full longer), and improves insulin sensitivity. The result: you naturally eat less without constant willpower battles. One weekly injection is all it takes.
You start at a low dose (0.25mg/week) and gradually increase over 4–8 weeks to minimize side effects like nausea. Most patients reach their target dose of 1.0–2.4mg/week within 8–12 weeks. Your provider adjusts the schedule based on your tolerance and results.
Individual results vary and are not guaranteed. Weight change depends on dose tolerance, diet, activity and individual physiology.
Take our 2-minute quiz to see if Compounded Semaglutide Injectable is right for you.
Start Your Free Assessment →